tert-Butyl 4-(4-amino-3-methylphenyl)piperidine-1-carboxylate
97%
- Product Code: 46302
CAS:
1383682-59-4
| Molecular Weight: | 290.40 g./mol | Molecular Formula: | C₁₇H₂₆N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30294365 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, protected from light, stored in an inert gas |
Product Description:
Used primarily in pharmaceutical research and development, this compound serves as an intermediate in the synthesis of various biologically active molecules. It is particularly valuable in the creation of compounds targeting neurological disorders, such as Parkinson's disease and depression, due to its piperidine and aromatic amine structure. Additionally, it is employed in the development of potential anticancer agents, where its structural framework aids in modulating cellular pathways. Its tert-butyl group enhances stability, making it suitable for further chemical modifications in drug discovery processes.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Off White Solid |
| PURITY | 96.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €54.87 |
+
-
|
| 0.250 | 10-20 days | €83.37 |
+
-
|
| 1.000 | 10-20 days | €186.63 |
+
-
|
| 5.000 | 10-20 days | €615.44 |
+
-
|
tert-Butyl 4-(4-amino-3-methylphenyl)piperidine-1-carboxylate
Used primarily in pharmaceutical research and development, this compound serves as an intermediate in the synthesis of various biologically active molecules. It is particularly valuable in the creation of compounds targeting neurological disorders, such as Parkinson's disease and depression, due to its piperidine and aromatic amine structure. Additionally, it is employed in the development of potential anticancer agents, where its structural framework aids in modulating cellular pathways. Its tert-butyl group enhances stability, making it suitable for further chemical modifications in drug discovery processes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :